Vadlamudi RK - Search Results

1

Therapeutic targeting of PELP1 prevents ovarian cancer growth and metastasis.

Chakravarty D, Roy SS, Babu CR, Dandamudi R, Curiel TJ, Vivas-Mejia P, Lopez-Berestein G, Sood AK, Vadlamudi RK. Chakravarty D, et al. Among authors: vadlamudi rk. Clin Cancer Res. 2011 Apr 15;17(8):2250-9. doi: 10.1158/1078-0432.CCR-10-2718. Epub 2011 Mar 18. Clin Cancer Res. 2011. PMID: 21421858 Free PMC article.

2

Potential role of a novel transcriptional coactivator PELP1 in histone H1 displacement in cancer cells.

Nair SS, Mishra SK, Yang Z, Balasenthil S, Kumar R, Vadlamudi RK. Nair SS, et al. Among authors: vadlamudi rk. Cancer Res. 2004 Sep 15;64(18):6416-23. doi: 10.1158/0008-5472.CAN-04-1786. Cancer Res. 2004. PMID: 15374949

3

Functional implications of altered subcellular localization of PELP1 in breast cancer cells.

Vadlamudi RK, Manavathi B, Balasenthil S, Nair SS, Yang Z, Sahin AA, Kumar R. Vadlamudi RK, et al. Cancer Res. 2005 Sep 1;65(17):7724-32. doi: 10.1158/0008-5472.CAN-05-0614. Cancer Res. 2005. PMID: 16140940 Free PMC article.

4

Comprehensive analysis of recent biochemical and biologic findings regarding a newly discovered protein-PELP1/MNAR.

Rajhans R, Vadlamudi RK. Rajhans R, et al. Among authors: vadlamudi rk. Clin Exp Metastasis. 2006;23(1):1-7. doi: 10.1007/s10585-006-9019-9. Epub 2006 Jul 7. Clin Exp Metastasis. 2006. PMID: 16826428 Review.

5

Emerging significance of ER-coregulator PELP1/MNAR in cancer.

Nair S, Vadlamudi RK. Nair S, et al. Among authors: vadlamudi rk. Histol Histopathol. 2007 Jan;22(1):91-6. doi: 10.14670/HH-22.91. Histol Histopathol. 2007. PMID: 17128415 Free PMC article. Review.

6

Functional and biological properties of the nuclear receptor coregulator PELP1/MNAR.

Vadlamudi RK, Kumar R. Vadlamudi RK, et al. Nucl Recept Signal. 2007 May 17;5:e004. doi: 10.1621/nrs.05004. Nucl Recept Signal. 2007. PMID: 17525794 Free PMC article. Review.

7

Oncogenic potential of the nuclear receptor coregulator proline-, glutamic acid-, leucine-rich protein 1/modulator of the nongenomic actions of the estrogen receptor.

Rajhans R, Nair S, Holden AH, Kumar R, Tekmal RR, Vadlamudi RK. Rajhans R, et al. Among authors: vadlamudi rk. Cancer Res. 2007 Jun 1;67(11):5505-12. doi: 10.1158/0008-5472.CAN-06-3647. Cancer Res. 2007. PMID: 17545633 Free PMC article.

8

Identifying the estrogen receptor coactivator PELP1 in autophagosomes.

Ohshiro K, Rayala SK, Kondo S, Gaur A, Vadlamudi RK, El-Naggar AK, Kumar R. Ohshiro K, et al. Among authors: vadlamudi rk. Cancer Res. 2007 Sep 1;67(17):8164-71. doi: 10.1158/0008-5472.CAN-07-0038. Cancer Res. 2007. PMID: 17804729

9

Modulation of in situ estrogen synthesis by proline-, glutamic acid-, and leucine-rich protein-1: potential estrogen receptor autocrine signaling loop in breast cancer cells.

Rajhans R, Nair HB, Nair SS, Cortez V, Ikuko K, Kirma NB, Zhou D, Holden AE, Brann DW, Chen S, Tekmal RR, Vadlamudi RK. Rajhans R, et al. Among authors: vadlamudi rk. Mol Endocrinol. 2008 Mar;22(3):649-64. doi: 10.1210/me.2007-0350. Epub 2007 Dec 13. Mol Endocrinol. 2008. PMID: 18079323 Free PMC article.

10

Growth factor regulation of estrogen receptor coregulator PELP1 functions via Protein Kinase A pathway.

Nagpal JK, Nair S, Chakravarty D, Rajhans R, Pothana S, Brann DW, Tekmal RR, Vadlamudi RK. Nagpal JK, et al. Among authors: vadlamudi rk. Mol Cancer Res. 2008 May;6(5):851-61. doi: 10.1158/1541-7786.MCR-07-2030. Mol Cancer Res. 2008. PMID: 18505929 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

210 results

Search Page

Filters